ResearcherUniversity of OttawaNo recent work listed

Henrique Afonseca Parsons

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-0436-4368; OpenAlex author ID A5044200630. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2016: 1 paper

Papers 1

The effects of curcumin (diferuloylmethane) on body composition of patients with advanced pancreatic cancer. Co-author DOI 10.18632/oncotarget.7773 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

James L. Abbruzzese · 1 shared paper, 2016 · strength 0.07
- Paper The effects of curcumin (diferuloylmethane) on body composition of patients with advanced pancreatic cancer. DOI 10.18632/oncotarget.7773 ↗
Eduardo D Bruera · 1 shared paper, 2016 · strength 0.07
- Paper The effects of curcumin (diferuloylmethane) on body composition of patients with advanced pancreatic cancer. DOI 10.18632/oncotarget.7773 ↗
Vickie Elaine Baracos · 1 shared paper, 2016 · strength 0.07
- Paper The effects of curcumin (diferuloylmethane) on body composition of patients with advanced pancreatic cancer. DOI 10.18632/oncotarget.7773 ↗
Razelle Kurzrock · 1 shared paper, 2016 · strength 0.07
- Paper The effects of curcumin (diferuloylmethane) on body composition of patients with advanced pancreatic cancer. DOI 10.18632/oncotarget.7773 ↗
David S. Hong · 1 shared paper, 2016 · strength 0.07
- Paper The effects of curcumin (diferuloylmethane) on body composition of patients with advanced pancreatic cancer. DOI 10.18632/oncotarget.7773 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.